(LDOS) Leidos Holdings, Inc. SWOT Analysis Research

US | Technology | Information Technology Services | NYSE
(LDOS) Leidos Holdings, Inc. SWOT Analysis Research

Fully Editable: Tailor To Your Needs In Excel Or Sheets

Professional Design: Trusted, Industry-Standard Templates

Investor-Approved Valuation Models

MAC/PC Compatible, Fully Unlocked

No Expertise Is Needed; Easy To Follow

(LDOS) Leidos Holdings, Inc. Bundle

Get Full Bundle:
$9 $5
$9 $5
$9 $5
$9 $5
$19 $9
$9 $5
$9 $5
$9 $5
$9 $5
Icon

Validate Every Claim with the Complete Sources File

This Leidos Holdings, Inc. SWOT Analysis gives a concise, company-specific breakdown of strengths, weaknesses, opportunities, and threats to support research, strategy, or investing; the page includes a real preview/sample so you can evaluate style and substance before buying. Purchase the full version to receive the complete, ready-to-use analysis instantly.

Icon

Strengths

Icon

3 Operating Segments

Leidos Holdings, Inc. runs three segments"Defense Solutions, Civil, and Health"which spreads FY2024 revenue of about $16.7 billion across both federal and commercial demand pools. That mix lowers dependence on any single mission area and supports cross-selling across programs. It also fits large government buying patterns, where one contract can span defense, civil, and health work.

Icon

1969 Founded

Founded in 1969, Leidos has over 55 years of operating history, which supports trust in regulated, mission-critical markets. That long record matters in defense, civil, and health contracts, where buyers often favor suppliers with deep procurement experience and proven delivery through multiple budget cycles. Its scale shows that strength too: Leidos reported about $16.7 billion in revenue in FY2024.

Explore a Preview
Icon

Defense Intelligence and NASA Reach

Leidos’s reach across the U.S. Intelligence Community, DoD, NASA, the military services, and allied governments gives it access to national security markets with high entry barriers. In FY2024, Leidos reported about $16.7 billion in revenue, showing the scale of these large, recurring programs. That customer mix also spreads demand across air, land, sea, space, and cyberspace.

FAA Mission Systems

Leidos Holdings, Inc.'s Civil segment is embedded in FAA modernization through ERAM, ATOP, TBFM, and TFDM, platforms tied to the FAA’s more than 45,000 daily flights. These long-cycle programs deepen integration, raise switching costs, and reinforce Leidos as a core aviation systems integrator.

  • Long FAA program cycles create sticky revenue.

Broad Digital Capability Set

Leidos Holdings, Inc. has a broad digital stack: cybersecurity, cloud, data analytics, DevOps, application modernization, and digital workplace services. That mix fits defense, civil, and health buyers that want secure IT modernization in one contract, not piecemeal tools.

In FY2025, this breadth helped Leidos compete for integrated programs and higher-value work across government IT spend, which keeps rising on security and legacy-system refresh needs.

  • One team, many digital services
  • Fits three major customer groups
  • Supports secure modernization demand
  • Improves win rates on bundled deals
Icon

Leidos’ Scale and Sticky Government Programs Power Its Edge

Leidos Holdings, Inc. strength comes from scale, with FY2025 revenue near $17 billion across Defense Solutions, Civil, and Health. Its long-running FAA, defense, and intelligence programs create sticky revenue and high switching costs. The broad digital stack also helps win bundled modernization work.

Key strength FY2025 data
Revenue scale ~$17.0B
Operating history 55+ years
Core segments 3

What is included in the product

Detailed Word Document icon

Detailed Word Document

Provides a clear SWOT framework for analyzing Leidos Holdings, Inc.’s business strategy

Customizable Excel Spreadsheet icon

Editable Excel File

Provides a quick, structured SWOT snapshot for Leidos Holdings, Inc. to simplify strategy review and decision-making.

References icon

Reference Sources

Provides a concise, traceable bibliography of industry reports, government data, and company filings to quickly validate Leidos market, pricing, and competitive assumptions.

Icon

Weaknesses

Icon

Federal Budget Exposure

Leidos is heavily tied to U.S. federal budgets, with defense and civil agencies making up most demand. That means continuing resolutions, shutdown risk, or delayed awards can push revenue out of one quarter into the next and weaken visibility. In its latest filings, Leidos still showed roughly 90% of sales linked to U.S. government customers, so budget timing stays a major weakness.

Icon

Program Concentration Risk

Leidos Holdings, Inc. faces program concentration risk because a large share of Civil work is tied to FAA and other modernization efforts, while Defense still leans on a few big agency contracts. That makes earnings more sensitive to delays, budget cuts, or scope changes in a single program. With backlog around $40 billion, one lost recompete can still hit results hard versus a broader mix.

Explore a Preview
Icon

Integration Heavy Model

Leidos’s systems-integrator model spans defense, civil, and health, but that also means results hinge on execution, subcontractors, and customer sign-off. In a business with roughly $16 billion in annual revenue, even one fixed-price program can squeeze margins fast and reduce flexibility versus product-heavy peers.

Complex Multi-Market Operations

Leidos Holdings, Inc. runs across four very different markets: defense, intelligence, civil aviation, and health. Each one has its own compliance, security, and procurement rules, so overhead rises and execution risk grows. That complexity can also slow decisions between divisions and make margin control harder.

  • Four markets, four rule sets
  • Higher overhead and execution risk
  • Slower cross-division decisions

Health Segment Scale Mix

Leidos Holdings, Inc. Health is a smaller mix inside a business that generated $16.7 billion of revenue in FY2024, so contract timing shifts can swing results more than in defense. Its federal and commercial work also faces tighter pricing and heavier competition, which can slow margin gains versus core national security programs.

  • Smaller than defense and civil
  • More timing-driven revenue swings
  • Commercial care is price sensitive
  • Margin growth can lag core work
Icon

Leidos’s Heavy U.S. Government Dependence Creates Earnings Risk

Leidos Holdings, Inc. stays exposed to U.S. federal budget timing, with about 90% of sales tied to government customers. Its backlog near $40 billion still leaves earnings vulnerable to one lost recompete or delayed award. A complex four-market mix and fixed-price programs can also pressure margins and slow decisions.

Weakness Data
Govt. exposure ~90% of sales
Backlog risk ~$40B
Revenue scale $16.7B FY2024

Preview Before You Purchase
Leidos Holdings, Inc. Reference Sources

This is the actual SWOT analysis document you’ll receive upon purchase—no surprises, just professional quality. The preview below is taken directly from the full SWOT report you'll get, covering Leidos Holdings, Inc.'s strengths, weaknesses, opportunities, and threats with actionable insights. Buy now to unlock the complete, editable version.

Explore a Preview
Icon

Opportunities

Icon

AI and Data Analytics Expansion

Leidos already delivers data analytics and intelligence support in mission settings, so AI can deepen work on current contracts and open new modernization wins. In FY2024, Leidos reported about $16.7 billion in revenue, showing the scale to package analytics with cybersecurity and systems integration. Demand for AI-enabled decision support keeps rising across defense and civil agencies, which should lift follow-on bookings.

Icon

FAA Modernization Pipeline

Leidos Holdings, Inc. stands to gain from the FAA modernization pipeline, since its Civil segment is tied to long-cycle air traffic control work. FAA FY2025 funding for facilities and equipment remains a major driver, with ERAM, ATOP, TBFM, and TFDM creating follow-on demand as the agency upgrades digital flight services and automation. Long program lives can keep revenue visibility strong.

Explore a Preview
Icon

Cybersecurity Demand

Leidos Holdings, Inc. can win more work as cybersecurity stays a top priority across national security and enterprise IT, especially where customers need secure systems and resilient operations. Its backlog was about $43 billion in 2025, showing room to bundle cyber into larger defense, civil, and health transformation deals. That mix helps Leidos turn cyber demand into recurring contract wins, not just one-off projects.

Digital Health and Life Sciences

Digital health and life sciences give Leidos Holdings, Inc. a growth path beyond defense cycles. Its Health segment serves health information management, managed care, digital transformation, and life sciences research, and in FY2025 Leidos generated about $16.7 billion in revenue, giving it scale to win more federal health and selected commercial work.

  • Expand federal health programs

  • Win data-modernization deals

  • Grow life sciences research

Allied and International Work

Leidos can grow beyond U.S. federal work because it already serves allied foreign governments and runs domestic and international programs. Rising defense, intelligence, and cyber spending across partner nations supports more bids in modernization and secure networks. That broadens the addressable market and lowers reliance on one customer base.

  • Serves allied foreign governments
  • Benefits from higher cyber demand
  • Diversifies end-market exposure
Icon

Leidos’ AI, Cyber, and Backlog Position It for More Growth

Leidos Holdings, Inc. can still grow by pairing AI, cyber, and mission systems across defense and civil contracts. FY2025 revenue was about $16.7 billion, and backlog was about $43 billion, so it has room to convert bids into longer work. FAA modernization, federal health, and allied security spending are the clearest openings.

Key data Value
FY2025 revenue about $16.7 billion
Backlog about $43 billion
Growth areas FAA, cyber, health
Icon

Threats

Icon

Federal Procurement Delays

Leidos’s exposure to federal procurement timing is high because its work is tied to contract awards, and delays from shutdowns or continuing resolutions can push revenue into later quarters. In its latest filings, Leidos reported roughly $16.7 billion in annual revenue and a backlog near $41 billion, so even short slippage can hit near-term visibility. The risk is sharpest in large defense and civil programs, where award timing can move billions of dollars.

Icon

Recompete Losses

Leidos depends on large, long-run government contracts, so recompetes are a real threat. In FY2024, Leidos generated about $16.7 billion in revenue, and a single lost contract can hit both sales and backlog fast. Rivals can undercut on price or promise newer tech, and in government services that pressure comes back every few years.

Explore a Preview
Icon

Intense Prime Contractor Competition

Leidos Holdings, Inc. faces hard prime-contractor rivalry from firms like Lockheed Martin, Booz Allen, Accenture, and KBR, each with scale, niche software, or deep agency ties. In U.S. federal bids, even a 1% change in win rate can swing hundreds of millions in backlog over a year. This pressure can squeeze gross margin and lift bid-and-proposal costs, which often run in the tens of millions on large pursuits.

Cyber and Mission Assurance Risk

Leidos Holdings, Inc. faces high cyber and mission-assurance risk because it supports defense, intelligence, civil, and health systems where one incident can trigger lost trust fast. In 2025, IBM said the average data breach cost hit $4.44 million, and regulated clients often add even more scrutiny after a breach or supplier failure.

A cybersecurity event, supply-chain compromise, or mission miss could bring remediation costs, contract reviews, and weaker renewal odds. These markets have near-zero tolerance for errors, so even small control gaps can hurt reputation and future awards.

  • High-trust contracts, low error tolerance
  • Breach costs can reach millions
  • Supplier gaps can trigger reviews
  • Incidents can damage renewals

Regulatory and Policy Shifts

Leidos Holdings, Inc. faces direct risk from changing defense, aviation, health, and data rules, especially because a large share of its business sits in U.S. government markets. In FY2025, Leidos reported about $16.7 billion in revenue and a backlog near $46 billion, so small rule changes can move a lot of future cash flow.

Shifts in procurement, export controls, cybersecurity, or healthcare policy can change bid terms, delay awards, and raise compliance spend. That matters because regulated programs often have fixed-price pressure, so extra legal, security, or reporting costs can hit margins fast.

For Leidos, the threat is not just lost work; it is also lower program economics when agencies tighten contract rules or data standards.

  • Rule changes can delay awards.
  • Compliance costs can lift fast.
  • Margins can shrink on fixed-price work.
Icon

Leidos Faces Funding Delays, Margin Pressure, and Recompete Risk

Leidos Holdings, Inc. is exposed to federal funding delays, with FY2025 revenue at about $16.7 billion and backlog near $46 billion, so shutdowns or continuing resolutions can shift awards and cash flow. Recompete losses and price pressure from peers can quickly hit margin and backlog. Cyber, compliance, and policy changes also raise remediation and bidding costs.

Threat FY2025 data
Revenue $16.7B
Backlog ~$46B

Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.